JP2024512741A5 - - Google Patents
Info
- Publication number
- JP2024512741A5 JP2024512741A5 JP2023560694A JP2023560694A JP2024512741A5 JP 2024512741 A5 JP2024512741 A5 JP 2024512741A5 JP 2023560694 A JP2023560694 A JP 2023560694A JP 2023560694 A JP2023560694 A JP 2023560694A JP 2024512741 A5 JP2024512741 A5 JP 2024512741A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- seq
- sequence shown
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163168606P | 2021-03-31 | 2021-03-31 | |
| US63/168,606 | 2021-03-31 | ||
| US202163249784P | 2021-09-29 | 2021-09-29 | |
| US63/249,784 | 2021-09-29 | ||
| US202263301305P | 2022-01-20 | 2022-01-20 | |
| US63/301,305 | 2022-01-20 | ||
| PCT/CA2022/050442 WO2022204793A1 (en) | 2021-03-31 | 2022-03-25 | Binding agents targeting tumors and/or immune cells |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024512741A JP2024512741A (ja) | 2024-03-19 |
| JP2024512741A5 true JP2024512741A5 (cg-RX-API-DMAC7.html) | 2025-04-03 |
Family
ID=83455216
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023560694A Pending JP2024512741A (ja) | 2021-03-31 | 2022-03-25 | 腫瘍及び/又は免疫細胞を標的化する結合剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240166739A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4314076A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024512741A (cg-RX-API-DMAC7.html) |
| AR (1) | AR125264A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174330A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TW202304993A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022204793A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4599066A1 (en) * | 2022-10-03 | 2025-08-13 | Kisoji Biotechnology Inc. | Multispecific binding agents targeting dopamine receptor d2 and methods of use thereof |
| CN120265659A (zh) * | 2022-10-25 | 2025-07-04 | 加拿大商木曾路生物科技公司 | 靶向表达cd36的肿瘤细胞的结合剂 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2009508521A (ja) * | 2005-09-23 | 2009-03-05 | アカデミッシュ ジーケンハイス レイデン | タンパク凝集に関連する疾患の診断予防及び治療のためのvhh |
| CA2747644C (en) * | 2008-12-19 | 2023-01-24 | Ablynx N.V. | Method for generation of immunoglobulin sequences |
| WO2011051327A2 (en) * | 2009-10-30 | 2011-05-05 | Novartis Ag | Small antibody-like single chain proteins |
| US20180222966A1 (en) * | 2013-04-29 | 2018-08-09 | Agrosavfe N.V. | Transgenic plant comprising a polynucleotide encoding a variable domain of heavy-chain antibody |
| US10874685B2 (en) * | 2014-04-17 | 2020-12-29 | The Royal Institution For The Advancement Of Learning/Mcgill University | Pancreatic cancer therapy and diagnosis |
| CA2975655C (en) * | 2015-02-05 | 2023-09-19 | Janssen Vaccines & Prevention B.V. | Binding molecules directed against influenza hemagglutinin and uses thereof |
| CA3065999A1 (en) * | 2017-05-24 | 2018-11-29 | Nanosomix, Inc. | Detection of biomarkers on vesicles for the diagnosis and prognosis of diseases and disorders |
| WO2019179434A1 (en) * | 2018-03-20 | 2019-09-26 | Wuxi Biologics (Shanghai) Co., Ltd. | Novel bispecific pd-1/cd47 antibody molecules |
| CN114072426B (zh) * | 2019-07-08 | 2024-01-26 | 南京金斯瑞生物科技有限公司 | 抗cd47/抗pd-1双特异抗体及其制备方法和应用 |
-
2022
- 2022-03-25 EP EP22778240.6A patent/EP4314076A4/en active Pending
- 2022-03-25 WO PCT/CA2022/050442 patent/WO2022204793A1/en not_active Ceased
- 2022-03-25 US US18/283,579 patent/US20240166739A1/en active Pending
- 2022-03-25 JP JP2023560694A patent/JP2024512741A/ja active Pending
- 2022-03-25 CA CA3174330A patent/CA3174330A1/en active Pending
- 2022-03-31 AR ARP220100796A patent/AR125264A1/es unknown
- 2022-03-31 TW TW111112543A patent/TW202304993A/zh unknown